Abstract

The use of hematopoietic cell transplantation has expanded and evolved substantially in the last decade. New stem cell sources and stem cell mobilizing agents have been introduced in clinical practice. The incidence of life-threatening complications following autologous stem cell transplant procedures has decreased dramatically. Understanding the immune mediated effect of allogeneic stem cell transplantation has resulted in the development of reduced intensity and non-myeloablative conditioning regimens, allowing transplantation of elderly patients. Long-term complications are starting to emerge, and will gain in importance in the near future.

Original languageEnglish (US)
Pages (from-to)1450-1456
Number of pages7
JournalAnnals of Oncology
Volume18
Issue number9
DOIs
StatePublished - Sep 1 2007

Fingerprint

Cell Transplantation
Stem Cells
Stem Cell Transplantation
Transplantation
Transplants
Incidence

Keywords

  • Allogeneic
  • Autologous
  • Stem cell transplantation

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Hematopoietic cell transplantation : Progress and obstacles. / DeVetten, Marcel P; Armitage, James Olen.

In: Annals of Oncology, Vol. 18, No. 9, 01.09.2007, p. 1450-1456.

Research output: Contribution to journalReview article

@article{0942910db0a0498bb3011ae0ead9af6a,
title = "Hematopoietic cell transplantation: Progress and obstacles",
abstract = "The use of hematopoietic cell transplantation has expanded and evolved substantially in the last decade. New stem cell sources and stem cell mobilizing agents have been introduced in clinical practice. The incidence of life-threatening complications following autologous stem cell transplant procedures has decreased dramatically. Understanding the immune mediated effect of allogeneic stem cell transplantation has resulted in the development of reduced intensity and non-myeloablative conditioning regimens, allowing transplantation of elderly patients. Long-term complications are starting to emerge, and will gain in importance in the near future.",
keywords = "Allogeneic, Autologous, Stem cell transplantation",
author = "DeVetten, {Marcel P} and Armitage, {James Olen}",
year = "2007",
month = "9",
day = "1",
doi = "10.1093/annonc/mdm064",
language = "English (US)",
volume = "18",
pages = "1450--1456",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Hematopoietic cell transplantation

T2 - Progress and obstacles

AU - DeVetten, Marcel P

AU - Armitage, James Olen

PY - 2007/9/1

Y1 - 2007/9/1

N2 - The use of hematopoietic cell transplantation has expanded and evolved substantially in the last decade. New stem cell sources and stem cell mobilizing agents have been introduced in clinical practice. The incidence of life-threatening complications following autologous stem cell transplant procedures has decreased dramatically. Understanding the immune mediated effect of allogeneic stem cell transplantation has resulted in the development of reduced intensity and non-myeloablative conditioning regimens, allowing transplantation of elderly patients. Long-term complications are starting to emerge, and will gain in importance in the near future.

AB - The use of hematopoietic cell transplantation has expanded and evolved substantially in the last decade. New stem cell sources and stem cell mobilizing agents have been introduced in clinical practice. The incidence of life-threatening complications following autologous stem cell transplant procedures has decreased dramatically. Understanding the immune mediated effect of allogeneic stem cell transplantation has resulted in the development of reduced intensity and non-myeloablative conditioning regimens, allowing transplantation of elderly patients. Long-term complications are starting to emerge, and will gain in importance in the near future.

KW - Allogeneic

KW - Autologous

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=34548401754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548401754&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdm064

DO - 10.1093/annonc/mdm064

M3 - Review article

VL - 18

SP - 1450

EP - 1456

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 9

ER -